Skip to main content
Erschienen in:

06.09.2024 | Case Report

Endoscopic ultrasound-guided fine-needle biopsy diagnosing pancreatic metastasis seven years after renal leiomyosarcoma resection: a case report

verfasst von: Takuya Okamoto, Shuhei Shintani, Hiromitsu Maehira, Kosuke Hiroe, Shiori Onoda, Hidenori Kimura, Atsushi Nishida, Masaji Tani, Ryoji Kushima, Osamu Inatomi

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Abstract

Renal leiomyosarcoma metastasis to the pancreas is exceptionally rare. Here, we present a case of metastatic recurrence in the pancreas seven years after renal leiomyosarcoma resection. A 73-year-old female with a history of renal leiomyosarcoma surgery seven years prior presented with a well-defined 40 × 30 mm pancreatic tail tumor detected by a computed tomography (CT) scan. The tumor exhibited hypo-enhancement in the arterial phase and a progressive enhancement pattern toward the equilibrium phase, similar to pancreatic cancer. Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) revealed bundles of spindle cells that matched those in the previously resected renal sample. Immunohistochemistry showed positive staining for desmin, confirming the diagnosis of pancreatic metastasis from renal leiomyosarcoma. The patient underwent a distal pancreatectomy to remove the metastatic lesion. The extended interval of seven years before the detection of metastasis underscores the challenges in monitoring and diagnosing metastatic patterns of renal leiomyosarcoma. EUS-FNB can assist in distinguishing metastatic pancreatic leiomyosarcoma from primary pancreatic cancer, thus influencing treatment decisions.
Literatur
1.
Zurück zum Zitat Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10:287–93.CrossRefPubMed Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10:287–93.CrossRefPubMed
2.
Zurück zum Zitat Crippa S, Angelini C, Mussi C, et al. Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg. 2006;30:1536–42.CrossRefPubMed Crippa S, Angelini C, Mussi C, et al. Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg. 2006;30:1536–42.CrossRefPubMed
3.
Zurück zum Zitat Ascenti G, Visalli C, Genitori A, et al. Multiple hypervascular pancreatic metastases from renal cell carcinoma: dynamic MR and spiral CT in three cases. Clin Imag. 2004;28:349–52.CrossRef Ascenti G, Visalli C, Genitori A, et al. Multiple hypervascular pancreatic metastases from renal cell carcinoma: dynamic MR and spiral CT in three cases. Clin Imag. 2004;28:349–52.CrossRef
4.
Zurück zum Zitat Suh CH, Keraliya A, Shinagare AB, et al. Multidetector computed tomography features of pancreatic metastases from leiomyosarcoma: experience at a tertiary cancer center. World J Radiol. 2016;8:316–21.CrossRefPubMedPubMedCentral Suh CH, Keraliya A, Shinagare AB, et al. Multidetector computed tomography features of pancreatic metastases from leiomyosarcoma: experience at a tertiary cancer center. World J Radiol. 2016;8:316–21.CrossRefPubMedPubMedCentral
5.
6.
Zurück zum Zitat Lee JD, Frederick RO. Leiomyosarcoma fo the rectum with hepatic metastasis. Case report. Mo Med. 1978;75:274–6.PubMed Lee JD, Frederick RO. Leiomyosarcoma fo the rectum with hepatic metastasis. Case report. Mo Med. 1978;75:274–6.PubMed
7.
Zurück zum Zitat Kershner D. Leiomyosarcoma of the stomach with hepatic metastasis; radical resection with surgical recovery. Gastroenterology. 1951;18:456–62.CrossRefPubMed Kershner D. Leiomyosarcoma of the stomach with hepatic metastasis; radical resection with surgical recovery. Gastroenterology. 1951;18:456–62.CrossRefPubMed
8.
Zurück zum Zitat Sugimoto M, Takahashi N, Farnell MB, et al. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: a propensity matching and intention-to-treat analysis. J Surg Oncol. 2019;120:976–84.CrossRefPubMed Sugimoto M, Takahashi N, Farnell MB, et al. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: a propensity matching and intention-to-treat analysis. J Surg Oncol. 2019;120:976–84.CrossRefPubMed
9.
Zurück zum Zitat Kanno A, Yasuda I, Irisawa A, et al. Adverse events of endoscopic ultrasound-guided fine-needle aspiration for histologic diagnosis in Japanese tertiary centers: multicenter retrospective study. Dig Endosc. 2021;33:1146–57.CrossRefPubMed Kanno A, Yasuda I, Irisawa A, et al. Adverse events of endoscopic ultrasound-guided fine-needle aspiration for histologic diagnosis in Japanese tertiary centers: multicenter retrospective study. Dig Endosc. 2021;33:1146–57.CrossRefPubMed
10.
Zurück zum Zitat DeWitt J, Jowell P, Leblanc J, et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc. 2005;61:689–96.CrossRefPubMed DeWitt J, Jowell P, Leblanc J, et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc. 2005;61:689–96.CrossRefPubMed
11.
Zurück zum Zitat Fikatas P, Klein F, Andreou A, et al. Long-term survival after surgical treatment of renal cell carcinoma metastasis within the pancreas. Anticancer Res. 2016;36:4273–8.PubMed Fikatas P, Klein F, Andreou A, et al. Long-term survival after surgical treatment of renal cell carcinoma metastasis within the pancreas. Anticancer Res. 2016;36:4273–8.PubMed
12.
Zurück zum Zitat Santoni M, Conti A, Partelli S, et al. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Ann Surg Oncol. 2015;22:2094–100.CrossRefPubMed Santoni M, Conti A, Partelli S, et al. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Ann Surg Oncol. 2015;22:2094–100.CrossRefPubMed
13.
Zurück zum Zitat Minni F, Casadei R, Perenze B, et al. Pancreatic metastases: observations of three cases and review of the literature. Pancreatology. 2004;4:509–20.CrossRefPubMed Minni F, Casadei R, Perenze B, et al. Pancreatic metastases: observations of three cases and review of the literature. Pancreatology. 2004;4:509–20.CrossRefPubMed
14.
Zurück zum Zitat Periasamy K, Dey T, Goyal S, et al. Primary renal leiomyosarcoma in adult patients: a systematic review and individual patient data analysis. African J Urol. 2024;30:15.CrossRef Periasamy K, Dey T, Goyal S, et al. Primary renal leiomyosarcoma in adult patients: a systematic review and individual patient data analysis. African J Urol. 2024;30:15.CrossRef
16.
17.
Zurück zum Zitat Itonaga M, Yasukawa S, Fukutake N, et al. Comparison of 22-gauge standard and franseen needles in EUS-guided tissue acquisition for diagnosing solid pancreatic lesions: a multicenter randomized controlled trial. Gastrointest Endosc. 2022;96(57–66):e52. Itonaga M, Yasukawa S, Fukutake N, et al. Comparison of 22-gauge standard and franseen needles in EUS-guided tissue acquisition for diagnosing solid pancreatic lesions: a multicenter randomized controlled trial. Gastrointest Endosc. 2022;96(57–66):e52.
18.
Zurück zum Zitat Alonso Gomez J, Arjona Sanchez A, Martinez Cecilia D, et al. Uterine leiomyosarcoma metastasis to the pancreas: report of a case and review of the literature. J Gastrointest Cancer. 2012;43:361–3.CrossRefPubMed Alonso Gomez J, Arjona Sanchez A, Martinez Cecilia D, et al. Uterine leiomyosarcoma metastasis to the pancreas: report of a case and review of the literature. J Gastrointest Cancer. 2012;43:361–3.CrossRefPubMed
19.
Zurück zum Zitat Miller JS, Zhou M, Brimo F, et al. Primary leiomyosarcoma of the kidney: a clinicopathologic study of 27 cases. Am J Surg Pathol. 2010;34:238–42.CrossRefPubMed Miller JS, Zhou M, Brimo F, et al. Primary leiomyosarcoma of the kidney: a clinicopathologic study of 27 cases. Am J Surg Pathol. 2010;34:238–42.CrossRefPubMed
20.
Zurück zum Zitat Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002;20:2824–31.CrossRefPubMed Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002;20:2824–31.CrossRefPubMed
21.
Zurück zum Zitat Maki RG. Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. Oncologist. 2007;12:999–1006.CrossRefPubMed Maki RG. Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. Oncologist. 2007;12:999–1006.CrossRefPubMed
22.
Zurück zum Zitat Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology. 2006;48:42–50.CrossRefPubMed Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology. 2006;48:42–50.CrossRefPubMed
23.
Zurück zum Zitat Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French federation of cancer centers sarcoma group. Cancer. 2001;91:1914–26.CrossRefPubMed Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French federation of cancer centers sarcoma group. Cancer. 2001;91:1914–26.CrossRefPubMed
24.
Zurück zum Zitat Zhuang A, Yue X, Tong H, et al. Nomogram predicting overall survival after surgical resection for retroperitoneal leiomyosarcoma patients. Front Endocrinol (Lausanne). 2023;14:1160817.CrossRefPubMed Zhuang A, Yue X, Tong H, et al. Nomogram predicting overall survival after surgical resection for retroperitoneal leiomyosarcoma patients. Front Endocrinol (Lausanne). 2023;14:1160817.CrossRefPubMed
25.
Zurück zum Zitat Deyrup AT, Montgomery E, Fisher C. Leiomyosarcoma of the kidney: a clinicopathologic study. Am J Surg Pathol. 2004;28:178–82.CrossRefPubMed Deyrup AT, Montgomery E, Fisher C. Leiomyosarcoma of the kidney: a clinicopathologic study. Am J Surg Pathol. 2004;28:178–82.CrossRefPubMed
26.
Zurück zum Zitat Hirota T, Tomida T, Iwasa M, et al. Solitary pancreatic metastasis occurring eight years after nephrectomy for renal cell carcinoma. A case report and surgical review. Int J Pancreatol. 1996;19:145–53.CrossRefPubMed Hirota T, Tomida T, Iwasa M, et al. Solitary pancreatic metastasis occurring eight years after nephrectomy for renal cell carcinoma. A case report and surgical review. Int J Pancreatol. 1996;19:145–53.CrossRefPubMed
Metadaten
Titel
Endoscopic ultrasound-guided fine-needle biopsy diagnosing pancreatic metastasis seven years after renal leiomyosarcoma resection: a case report
verfasst von
Takuya Okamoto
Shuhei Shintani
Hiromitsu Maehira
Kosuke Hiroe
Shiori Onoda
Hidenori Kimura
Atsushi Nishida
Masaji Tani
Ryoji Kushima
Osamu Inatomi
Publikationsdatum
06.09.2024
Verlag
Springer Nature Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 6/2024
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-024-02033-7

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Antibiotika bei Bakteriämie – 7 versus 14 Tage

  • 21.01.2025
  • Sepsis
  • Nachrichten

Eine Bakteriämie lässt sich mit einer einwöchigen Antibiotikatherapie zumeist gut in den Griff bekommen: Die Sterberate ist nicht höher als unter zweiwöchiger Behandlung, zeigt eine Vergleichsstudie mit hospitalisierten Erkrankten. Allerdings muss die Therapie bei fast jedem Vierten verlängert werden.

"Die Erektionsstörung ist keine isolierte Erkrankung"

Werden Erektionsstörungen gut behandelt (und das ist möglich), steigt die Lebensqualität enorm. Tipps für eine gute Kommunikation mit den Patienten gibt Androloge Dr. med. Jann-Frederik Cremers in dieser Folge. Welche Fragen sollten gestellt und an welche Ursachen gedacht werden? Und was ist zu tun, wenn PDE-5-Hemmer und Lebensstilveränderungen nicht ausreichend wirken?

Lp(a) zur Risikoeinschätzung bei Thoraxschmerzen

Der Lp(a)-Wert kann dazu beitragen, bei stabilen Patienten mit neu aufgetretenen Thoraxschmerzen und ohne KHK-Diagnose die Wahrscheinlichkeit für das Vorliegen von Koronarstenosen abzuschätzen.

Finerenon bei eGFR-Verlust nicht gleich absetzen!

Der Mineralokortikoid-Rezeptor-Antagonist Finerenon verbessert die Prognose bei Herzinsuffizienz mit leicht reduzierter oder erhaltener Ejektionsfraktion. Ein Rückgang der eGFR zu Beginn der Therapie scheint diese Wirkung nicht wesentlich zu mindern.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.